Medizinische Universität Graz - Research portal

Go directly to the nagivation.
Go directly to the content.

Print view.
German.
Contact.
Data entry.
Start.
Open Access.

Navigation/Search

Researchers.
Institutions.
Projects.
Publications.
Partners.
Sponsors.
Equipment.
Knowhow.
Fields of Research.

Selected Publication:

Vergote, IB; Joly, F; Katsaros, D; Coens, C; Reinthaller, A; Hall, M; Steer, CB; Colombo, N; Lesoin, A; Casado, A; Petru, E; Green, J; Buck, M; Ray-Coquard, IL; Ferrero, A; Favier, L; Reed, N; Curve, H; Jimeno, A; Pujade-Lauraine, E; .
Randomized phase III study of erlotinib versus observation in patients with no evidence of disease progression after first-line platin-based chemotherapy for ovarian carcinoma: A GCIG and EORTC-GCG study.
J CLIN ONCOL. 2012; 30(18):-48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO); JUN 01-05, 2012; Chicago, IL. [Oral Communication]
Web of Science

Authors Med Uni Graz:: Petru Edgar
Altmetrics: